In vivo acute exposure to polychlorinated biphenyls: Effects on free and total thyroxine in rats

International Journal of Toxicology

Volumn 28, Issue 5, 2009, Pages 382-391

  Hedge, J M ^a   DeVito, M J ^a   Crofton, K M ^a  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Endocrine disruptors; Free thyroxine; Polychlorinated biphenyls; Thyroid hormones; Total thyroxine

Indexed keywords

2,2',4,4',5,5' HEXACHLOROBIPHENYL; 3,3',4,4',5,5' HEXACHLOROBIPHENYL; ETHOXYRESORUFIN DEETHYLASE; GLUCURONOSYLTRANSFERASE; PENTOXYRESORUFIN O DEETHYLASE; POLYCHLORINATED BIPHENYL DERIVATIVE; THYROXINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EXPOSURE; FEMALE; HYPOTHYROIDISM; IN VIVO STUDY; LIVER MICROSOME; NONHUMAN; RAT; THYROXINE BLOOD LEVEL;

ADMINISTRATION, ORAL; AGING; ANIMALS; CYTOCHROME P-450 CYP1A1; CYTOCHROME P-450 CYP2B1; ENDOCRINE DISRUPTORS; FEMALE; MICROSOMES, LIVER; POLYCHLORINATED BIPHENYLS; RADIOIMMUNOASSAY; RATS; RATS, LONG-EVANS; THYROXINE;

RATTUS;

EID: 73149088415     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581809344631     Document Type: Article

References (51)

1. Goldey ES, Kehn LS, Lau C, Rehnberg GL, Crofton KM. Developmental exposure to polychlorinated biphenyls (Aroclor 1254) reduces circulating thyroid hormone concentrations and causes hearing deficits in rats. Toxicol Appl Pharmacol. 1995;135:77-88.
2. Craft ES, DeVito MJ, Crofton KM. Comparative responsiveness of hypothyroxinemia and hepatic enzyme induction in Long-Evans rats versus C57BL/6J mice exposed to TCDD-like and phenobarbital-like polychlorinated biphenyl congeners. Toxicol Sci. 2002;68:372-380.
3. Morse DC, Groen D, Veerman M, et al. Interference of polychlorinated biphenyls in hepatic and brain thyroid hormone metabolism in fetal and neonatal rats. Toxicol Appl Pharmacol. 1993;122:27-33.
4. Brouwer A, Morse DC, Lans MC, et al. Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Indust Health. 1998;14:59-84.
5. Brucker-Davis F. Effects of environmental synthetic chemicals on thyroid function. Thyroid. 1998;8:827-856.
6. Desaulniers D, Leingartner K, Wade M, Fintelman E, Yagminas A, Foster WG. Effects of acute exposure to PCBs 126 and 153 on anterior pituitary and thyroid hormones and FSH isoforms in adult Sprague Dawley male rats. Toxicol Sci. 1999;47:158-169.
7. Hood A, Klaassen CD. Differential effects of microsomal enzyme inducers on in vitro thyroxine (T(4)) and triiodothyronine (T(3)) glucuronidation. Toxicol Sci. 2000;55:78-84.
8. Bastomsky CH, Murthy PV. Enhanced in vitro hepatic glucuronidation of thyroxine in rats following cutaneous application or ingestion of polychlorinated biphenyls. Can J Physiol Pharmacol. 1976;54:23-26.
9. Vansell NR, Klaassen CD. Increased biliary excretion of thyroxine by microsomal enzyme inducers. Toxicol Appl Pharmacol. 2001;176:187-194.
10. Auyeung DJ, Kessler FK, Ritter JK. Mechanism of rat UDP- glucuronosyltransferase 1A6 induction by oltipraz: evidence for a contribution of the Aryl hydrocarbon receptor pathway. Mol Pharmacol. 2003;63:119-127
11. Guo GL, Choudhuri S, Klaassen CD. Induction profile of rat organic anion transporting polypeptide 2 (oatp2) by prototypical drug-metabolizing enzyme inducers that activate gene expression through ligand-activated transcription factorpathways. JPharmacolExpTher. 2002;300:206-212.
12. Martin LA. Differential effects of polychlorinated biphenyl (PCB) mixtures and congeners on the disposition of thyroxine (T4) in rats [PhD thesis]. Rutgers University and Robert Wood Johnson Medical School; 2002: p.165.
13. Brouwer A. Inhibition of thyroid hormone transport in plasma of rats by polychlorinated biphenyls. Arch Toxicol Suppl. 1989;13:440-445.
14. Chauhan KR, Kodavanti PR, McKinney JD. Assessing the role of ortho-substitution on polychlorinated biphenyl binding to transthyretin, a thyroxine transport protein. Toxicol Appl Pharmacol. 2000;162:10-21.
15. Cheek AO, Kow K, Chen J, McLachlan JA. Potential mechanisms of thyroid disruption in humans: interaction of organochlorine compounds with thyroid receptor, transthyretin, and thyroid-binding globulin. Environ Health Perspect. 1999;107:273-278.
16. Lans MC, Klasson-Wehler E, Willemsen M, Meussen E, Safe S, Brouwer A. Structure-dependent, competitive interaction of hydroxy-polychlorobiphenyls, -dibenzo-pdioxins and -dibenzofurans with human transthyretin. Chem Biol Interact. 1993;88:7-21.
17. Larsson M, Pettersson T, Carlstrom A. Thyroid hormone binding in serum of 15 vertebrate species: isolation of thyroxine-binding globulin and prealbumin analogs. Gen Comp Endocrinol. 1985;58:360-375.
18. Savu L, Vranckx R, Maya M, Gripois D, Blouquit MF, Nunez EA. Thyroxine-binding globulin and thyroxinebinding prealbumin in hypothyroid and hyperthyroid developing rats. BiochimBiophys Acta. 1989;992:379-384.
19. Savu L, Vranckx R, Maya M, Nunez EA. A thyroxine binding globulin (TBG)-like protein in the sera of developing and adult rats. Biochem Biophys Res Commun. 1987;148:1165-1173.
20. Vranckx R, Rouaze M, Savu L, Nunez EA, Beaumont C, Flink IL. The hepatic biosynthesis of rat thyroxine binding globulin (TBG): demonstration, ontogenesis, and upregulation in experimental hypothyroidism. Biochem Biophys Res Commun. 1990;167:317-322.
21. Vranckx R, Rouaze-Romet M, Savu L, Mechighel P, Maya M, Nunez EA. Regulation of rat thyroxine-binding globulin and transthyretin: studies in thyroidectomized and hypophysectomized rats given tri-iodothyronine or/and growth hormone. J Endocrinol. 1994;142:77-84.
22. Rouaze-Romet M, Savu L, Vranckx R, et al. Reexpression of thyroxine-binding globulin in postweaning rats during protein or energy malnutrition. Acta Endocrinol (Copenh). 1992;127:441-448.
23. Young RA, Rajatanavin R, Moring AF, Braverman LE. Fasting induces the generation of serum thyroninebinding globulin in Zucker rats. Endocrinology. 1985;116:1248-1252.
24. Lans MC, Spiertz C, Brouwer A, Koeman JH. Different competition of thyroxine binding to transthyretin and thyroxine-binding globulin by hydroxy-PCBs, PCDDs and PCDFs. Eur J Pharmacol. 1994;270:129-136.
25. Rickenbacher U, McKinney JD, Oatley SJ, Blake CC. Structurally specific binding of halogenated biphenyls to thyroxine transport protein. J Med Chem. 1986;29:641-648.
26. Abbott BD, Birnbaum LS, Diliberto JJ. Rapid distribution of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) to embryonic tissues in C57BL/6N mice and correlation with palatal uptake in vitro. Toxicol Appl Pharmacol. 1996;141:256-263.
27. Wang X, Santostefano MJ, Evans MV, Richardson VM, Diliberto JJ, Birnbaum LS. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats. Toxicol Appl Pharmacol. 1997;147:151-168.
28. Dohler KD, Wong CC, von zur Muhlen A. The rat as model for the study of drug effects on thyroid function: consideration of methodological problems. Pharmacol Ther [B]. 1979;5:305-318.
29. Crofton KM, Craft ES, Hedge JM, et al. Thyroid hormone disrupting chemicals: Evidence for dosedependent additivity and synergism. Environ Health Perspect. 2005;113:1549-1554.
30. DeVito MJ, Menache MG, Dilberto JJ, Ross DG, Birnbaum LS. Dose-response relationships for induction of CYP1A1 and CYP1A2 enzyme activity in liver, lung, and skin in female mice following subchronic exposure to polychlorinated biphenyls. Toxicol Appl Pharmacol. 2000;167:157-172.
31. Safe SH. Polychlorinated biphenyls (PCBs): Environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol. 1994;24:87-148.
32. DeVito MJ, Maier WE, Diliberto JJ, Birnbaum LS. Comparative ability of various PCBs, PCDFs, and TCDD to induce cytochrome P450 1A1 and 1A2 activity following 4 weeks of treatment. Fundam Appl Toxicol. 1993;20:125-130.
33. Ganem LG, Trottier E, Anderson A, Jefcoate CR. Phenobarbital induction of CYP2B1/2 in primary hepatocytes: Endocrine regulation and evidence for a single pathway for multiple inducers. Toxicol Appl Pharmacol. 1999;155:32-42.
34. Parkinson A, Safe SH, Robertson LW, et al. Immunochemical quantitation of cytochrome P-450 isozymes and epoxide hydrolase in the liver microsomes from polychlorinated or polybrominated biphenyl-treated rats. A study of structure-activity relationships. J Biol Chem. 1983;258:5967-5976.
35. Visser TJ, Kaptein E, van Toor H, et al. Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology. 1993;133:2177-2186.
36. Zhou T, Ross DG, DeVito MJ, Crofton KM. Effects of short-term in vivo exposure to polybrominated diphenyl ethers on thyroid hormones and hepatic enzyme activities in weanling rats. Toxicol Sci. 2001;61:76-82.
37. Darnerud PO, Morse D, Klasson-Wehler E, Brouwer A. Binding of a 3,3', 4,4'-tetrachlorobiphenyl (CB-77) metabolite to fetal transthyretin and effects on fetal thyroid hormone levels in mice. Toxicology. 1996;106:105-114.
38. Barter RA, Klaassen CD. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP- glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol. 1994;128:9-17.
39. Kodavanti PR, Derr-Yellin EC, Mundy WR, et al. Repeated exposure of adult rats to Aroclor 1254 causes brain region-specific changes in intracellular Ca2β buffering and protein kinase C activity in the absence of changes in tyrosine hydroxylase. Toxicol Appl Pharmacol. 1998;153:186-198.
40. Morse DC, Wehler EK, Wesseling W, Koeman JH, Brouwer A. Alterations in rat brain thyroid hormone status following pre- and postnatal exposure to polychlorinated biphenyls (Aroclor 1254). Toxicol Appl Pharmacol. 1996;136:269-279.
41. Stockigt JR. Free thyroid hormone measurement. A critical appraisal. Endocrinol Metab Clin North Am. 2001; 30:265-289.
42. Holm SS, Andreasen L, Hansen SH, Faber J, Staun- Olsen P. Influence of adsorption and deproteination on potential free thyroxine reference methods. Clin Chem. 2002;48:108-114.
43. Fisher JW, Campbell J, Muralidhara S, et al. Effect of PCB 126 on hepatic metabolism of thyroxine and perturbations in the hypothalamic-pituitary-thyroid axis in the rat. Toxicol Sci. 2006;90:87-95.
44. Davis PJ, Spaulding SW, Gregerman RI. The three thyroxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology. 1970;87:978-986.
45. Sapin R. Serum thyroxine binding capacity-dependent bias in five free thyroxine immunoassays: assessment with serum dilution experiments and impact on diagnostic performance. Clin Biochem. 2001;34:367-371.
46. Barter RA, Klaassen CD. UDP-glucuronosyltransferase inducers reduce thyroid hormone levels in rats by an extrathyroidal mechanism. Toxicol Appl Pharmacol. 1992;113:36-42.
47. Wong H, Lehman-McKeeman LD, Grubb MF, et al. Increased hepatobiliary clearance of unconjugated thyroxine determines DMP 904-induced alterations in thyroid hormone homeostasis in rats. Toxicol Sci. 2005; 84:232-242.
48. DeVito M, Biegel L, Brouwer A, et al. Screening methods for thyroid hormone disruptors. Environ Health Perspect. 1999;107:407-415.
49. Chen C, Staudinger JL, Klaassen CD. Nuclear receptor, pregname X receptor, is required for induction of UDP-glucuronosyltranferases in mouse liver by pregnenolone-16 alpha-carbonitrile. Drug Metab Dispos. 2003;31:908-915.
50. Schuetz EG, Brimer C, Schuetz JD. Environmental xenobiotics and the antihormones cyproterone acetate and spironolactone use the nuclear hormone pregnenolone X receptor to activate the CYP3A23 hormone response element. Mol Pharmacol. 1998; 54:1113-1117.
51. Kato Y, Ikushiro S, Takiguchi R, et al. A novel mechanism for polychlorinated biphenyl-induced decrease in serum thyroxine levels in rats. Drug Metab Dispos. 2007;35:1949-1955.